{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-009221","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.547417+00:00","generated_at":"2026-05-16T10:52:16.857266+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Jaguar Health issues $350K in 6% notes and warrants for 350K shares at $1.00","bullets":["Issued $350,000 aggregate principal amount of unsecured promissory notes to two accredited investors.","Notes bear 6% annual interest and mature one month from issuance; prepayable without penalty.","Investors received warrants to purchase up to 350,000 shares of common stock at $1.00/share, exercisable immediately for five years.","Proceeds used for working capital and general corporate purposes; transaction closed January 5, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-009221","json":"https://secwatch.observer/filing/0001193125-26-009221.json","markdown":"https://secwatch.observer/filing/0001193125-26-009221.md","text":"https://secwatch.observer/filing/0001193125-26-009221.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526009221/0001193125-26-009221-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526009221/jagx-20260105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:52:16.857266+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b6e1a9570f1279a2e866406254e41b807de21d8e","claim":"Jaguar Health, Inc. incurred senior notes of $350,000 aggregate principal amount at 6% per annum maturing one month after issuance.","evidence_excerpt":"On January 5, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526009221/0001193125-26-009221-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$350,000 aggregate principal amount"},{"label":"Rate","value":"6% per annum"},{"label":"Maturity","value":"one month after issuance"},{"label":"Event","value":"incurrence"}]},{"claim_id":"2166959f870a90a7916ffb2bebe463fef435c783","claim":"Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 (effective 2026-01-05).","evidence_excerpt":"On January 5, 2026 (the \"Execution Date\"), Jaguar Health, Inc. (the \"Company\") entered into securities purchase agreements (the \"Securities Purchase Agreements\") with two accredited investors (each, an \"Investor\"), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526009221/0001193125-26-009221-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"two accredited investors"},{"label":"Value","value":"$350,000"},{"label":"Effective","value":"2026-01-05"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}